Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. | 0 | déclaré | 18 nov. 2024 | tx 24+889 166−203 332 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 18 nov. 2024 | SALE | Syros Pharmaceuticals, Inc. | 134 797 | 0.20 USD | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | — | |
| 31 oct. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 8 707 | 2.09 USD | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | 0.00 USD | deriv |
| 10 sept. 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 50 000 | 1.51 USD | |
| 11 sept. 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 50 000 | 1.71 USD | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11 666 | — | |
| 01 avr. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 3 500 | 5.12 USD | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11 666 | 0.00 USD | deriv |
| 02 déc. 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 86 000 | 0.00 USD | deriv |
| 01 nov. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6 004 | 2.22 USD | |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | — | |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | 0.00 USD | deriv |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 03 avr. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 658 | 2.58 USD | |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
| 16 févr. 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 35 000 | 0.00 USD | deriv |
| 15 févr. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 80 000 | 0.00 USD | deriv |
| 15 févr. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 100 000 | 0.00 USD | deriv |
| 27 sept. 2021 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 360 000 | 0.00 USD | deriv |